Literature DB >> 493874

Quantitative evaluation of the mechanisms of the anaemia in heterozygous beta-thalassaemia.

M Cazzola, P Alessandrino, G Barosi, S Morandi, M Stefanelli.   

Abstract

Ferrokinetic studies were carried out in 8 patients with heterozygous beta-thalassaemia with anaemia of varying severity. Effective and ineffective erythropoiesis, mean red cell lifespan and non-erythroid iron turnover were estimated from the experimental data through a mathematical model of iron kinetics. Erythropoietic activity was markedly increased in all patients, but was variably ineffective (from 10 to 74%). A negative correlation (r = 0.855, P less than 0.01) was found between the amount of ineffective erythropoiesis and Hb level. Red cell lifespan was variably shortened and there was a negative correlation between the degree of daily peripheral haemolysis and Hb level (r = 0.733, P less than 0.05). Non-erythroid iron turnover was increased in most patients. The results provide quantitative measurements of the mechanisms responsible for the wide variation of the Hb level in heterozygous beta-thalaeeaemia. Ineffective erythropoiesis seems to be the major reason for the anaemia. Peripheral haemolysis contributes to it, especially in the most severely affected patients. The increased non-erythroid iron turnover may be responsible for the pathology which characterizes heterozygotes in the adult life.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 493874     DOI: 10.1111/j.1600-0609.1979.tb02680.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  An aberrant type of congenital dyserythropoietic anemia associated with a beta-thalassemia trait.

Authors:  G Sansone; L Lupi
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

2.  A mathematical model of iron metabolism.

Authors:  P C Franzone; A Paganuzzi; M Stefanelli
Journal:  J Math Biol       Date:  1982       Impact factor: 2.259

3.  Preclinical transfusion-dependent humanized mouse model of beta thalassemia major.

Authors:  Yongliang Huo; Sean C McConnell; Thomas M Ryan
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.